Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 4 (2007), Issue 1 (January)

1. Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1.
   FASEB J. [Abstract] [Full-text]
2. Preventive effects of treatment of disruptive behavior disorder in middle childhood on substance use and delinquent behavior.
   J Am Acad Child Adolesc Psychiatry, 46(1): 33-9. [Abstract] [Full-text]
3. Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania.
   Arch Gen Psychiatry, 64(1): 57-64. [Abstract] [Full-text]
4. The role of CYP2A6 in the emergence of nicotine dependence in adolescents.
   Pediatrics, 119(1): e264-74. [Abstract] [Full-text]
5. Contrasting models of genetic co-morbidity for cannabis and other illicit drugs in adult Australian twins.
   Psychol Med, 37(1): 49-60. [Abstract] [Full-text]
6. Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
   PLoS ONE, 1: e114. [Abstract] [Full-text]
7. A latent class analysis of illicit drug abuse/dependence: results from the National Epidemiological Survey on Alcohol and Related Conditions.
   Addiction, 102(1): 94-104. [Abstract] [Full-text]
8. The effect of assertive continuing care on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders.
   Addiction, 102(1): 81-93. [Abstract] [Full-text]
9. The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosis.
   Addiction, 102(1): 35-40. [Abstract] [Full-text]
10. Binge drinking and health behavior in medical students.
    Addict Behav, 32(3): 505-15. [Abstract] [Full-text]
11. Relation of physiological reactivity and perceived coping to substance use disorders.
    Addict Behav, 32(3): 608-16. [Abstract] [Full-text]
12. Characteristics and HIV risk behaviors of homeless, substance-using men who have sex with men.
    Addict Behav, 32(3): 647-54. [Abstract] [Full-text]
13. Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS.
    J Mass Spectrom. [Abstract] [Full-text]
14. Fidelity of implementation in a treatment effectiveness trial of Reconnecting Youth.
    Health Educ Res, 22(1): 95-107. [Abstract] [Full-text]
15. Association of substance-use behaviours and their social-cognitive determinants in secondary school students.
    Health Educ Res, 22(1): 81-94. [Abstract] [Full-text]
16. The role of childhood risk factors in initiation of alcohol use and progression to alcohol dependence.
    Addiction, 102(2): 216-25. [Abstract] [Full-text]
17. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.
    Eur J Pharmacol, 556(1): 75-83. [Abstract] [Full-text]
18. Effects of backpacking holidays in Australia on alcohol, tobacco and drug use of UK residents.
    BMC Public Health, 7: 1. [Abstract] [Full-text]
19. Prevalence and factors associated with alcohol and drug-related disorders in prison: a French national study.
    Subst Abuse Treat Prev Policy, 2: 1. [Abstract] [Full-text]
20. Cannabimimetic properties of ajulemic acid.
    J Pharmacol Exp Ther, 320(2): 678-86. [Abstract] [Full-text]
21. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
    J Dermatol Sci, 45(2): 87-92. [Abstract] [Full-text]
22. The check-up: in-person, computerized, and telephone adaptations of motivational enhancement treatment to elicit voluntary participation by the contemplator.
    Subst Abuse Treat Prev Policy, 2: 2. [Abstract] [Full-text]
23. Effects of frequent cannabis use on hippocampal activity during an associative memory task.
    Eur Neuropsychopharmacol, 17(4): 289-97. [Abstract] [Full-text]
24. Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats.
    Eur J Pharmacol, 557(1): 37-43. [Abstract] [Full-text]
25. Negative consequences associated with dependence in daily cannabis users.
    Subst Abuse Treat Prev Policy, 2: 3. [Abstract] [Full-text]
26. Explaining associations between adolescent substance use and condom use.
    J Adolesc Health, 40(2): 180.e1-18. [Abstract] [Full-text]
27. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.
    Curr Med Res Opin, 23(1): 17-24. [Abstract] [Full-text]

© 2004-2013 Marijuana Research Today. All Rights Reserved.